Targeting PTPN22 in Arthritis: Molecular docking and Pharmacokinetic evaluation of Artemisia vestita compounds

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume :03 | Issue : 01 | Page : –
    By

    Shweta V Bhat,

  1. Student, Department of Bioinformatics, BioNome, Bengaluru, Karnataka, India

Abstract

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_151367’);});Edit Abstract & Keyword

Rheumatoid arthritis (RA) is a long-term autoimmune condition characterized by inflammation of the synovial membrane, commonly resulting in swelling, pain, stiffness, and overall fatigue. Protein tyrosine phosphatase non-receptor type 22 (PTPN22) has been identified as a risk factor linked to various autoimmune diseases, including rheumatoid arthritis (RA).In the PTPN22 gene, two missense Single nucleotide polymorphisms (SNPs) are associated with autoimmune conditions. The R620W (C1858T, rs247660) variant in exon 14 has been shown to elevate the negative regulation of B and T cell activation. On the other hand, the R263Q (G788A, rs33396649) variant in exon 10 affects enzyme activity by altering a key amino acid. This study explores the potential of the phytochemical compounds from Artemisia vestita, a folklore medicinal plant with anti-inflammatory and antipyretic properties in the treatment of RA using computational tools. PyRx, a virtual screening software was employed to carry out the molecular docking stimulations. The compounds from A. vestita which demonstrated the most favourable binding with PTPN22 were Vulgarin, Thujyl alcohol, iso-3-Thujyl acetate, (+)-alpha-Thujone and Verbenone. These compounds were chosen for further in silico analysis and were evaluated for drug-like properties on the basis of ADMET parameters, Lipinski’s rule of five and five physiochemical parameters: Bioavailability score, GI absorption, PAINS and Brenk alerts and solubility. The compound Vulgarin exhibited the best affinity towards PTPN22. Hence, the molecular interaction between PTPN22 and Vulgarin was visualized in DS BIOVIA Discovery Studio Visualizer.

Keywords: Rheumatoid arthritis; Artemisia vestita; Protein tyrosine phosphatase non-receptor type 22(PTPN22); Molecular docking; In silico analysi

[This article belongs to International Journal of Bioinformatics and Computational Biology (ijbcb)]

How to cite this article:
Shweta V Bhat. Targeting PTPN22 in Arthritis: Molecular docking and Pharmacokinetic evaluation of Artemisia vestita compounds. International Journal of Bioinformatics and Computational Biology. 2025; 03(01):-.
How to cite this URL:
Shweta V Bhat. Targeting PTPN22 in Arthritis: Molecular docking and Pharmacokinetic evaluation of Artemisia vestita compounds. International Journal of Bioinformatics and Computational Biology. 2025; 03(01):-. Available from: https://journals.stmjournals.com/ijbcb/article=2025/view=0

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_151367’);});Edit

References

  1. Andrea, Di, Matteo., Joan, M., Bathon., Paul, Emery. Rheumatoid arthritis. The Lancet, (2023).;402(10416):2019-2033. doi: 10.1016/s0140-6736(23)01525-8.
  2. Huang J, Fu X, Chen X, Li Z, Huang Y, Liang C. Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. Front Immunol. 2021 Jul 9;12:686155. doi: 10.3389/fimmu.2021.686155. PMID: 34305919; PMCID: PMC8299711.
  3. Ruibo, Li., Xingyue, Yuan., Yili, Ou. (2024). Global burden of rheumatoid arthritis among adolescents and young adults aged 10–24 years: A trend analysis study from 1990 to 2019. PLOS ONE, 19 doi: 10.1371/journal.pone.0302140.
  4. Wan L, Liu J, Huang C, Chen X, Zhao L, Fan H, Ge Y, Liu T, Liu L. [Inflammation caused by different immune cell subsets is involved in bone destruction of rheumatoid arthritis]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020 Nov;36(11):1026-1031. Chinese. PMID: 33210598.
  5. Federico, Dı́az-González., María, Hernández-Hernández. Rheumatoid arthritis. Medicina Clínica (english Edition), (2023).;161(12):533-542. doi: 10.1016/j.medcle.2023.07.008.
  6. Mathias, Iven. Rheumatoid arthritis. (2023).317-327. doi: 10.1016/b978-0-323-91890-9.00008-8.
  7. Ihor, Korol., Robin, H., Baumeister. Treating rheumatoid arthritis. (2023).;36:1-5. doi: 10.1097/01.jaa.0000937316.70181.ff.
  8. Premanand, A, Nighojkar., Munira, Momin., Suvarna, P., Phadatare. Rheumatoid arthritis – Pharmacology and its management with traditional herbs. (2017).
  9. Diaz-Gallo, Lina-Marcela, and Javier Martin. “PTPN22 splice forms: a new role in rheumatoid arthritis.” Genome medicine vol. 4,2 13. 24 Feb. 2012, doi:10.1186/gm312.
  10. Usman, Pasha., Haseeb, Nisar., Hajira, Nisar., R, Abid., Naeem, Mahmood, Ashraf., Saima, Sadaf. Molecular Dynamic Simulations Unravel the Underlying Impact of Missense Mutation in Autoimmunity Gene PTPN22 on Predisposition to Rheumatoid Arthritis.. Journal of Interferon and Cytokine Research, (2023).;43(3):121-132. doi: 10.1089/jir.2022.0216.
  11. Ahmed, Redha, Taher., Nktel, Faaz, Nassir. The PTPN22 as Master Regulation in Autoimmune Diseases and Its Susceptibility to Rheumatoid Arthritis. South Asian research journal of biology and applied biosciences, (2024).;6(04):94-107. doi: 10.36346/sarjbab.2024.v06i04.001.
  12. Vishnu, Mittal., Ashima, Barak., Abhinav, Singhal. Nature’s Pharmacy: Herbal Interventions in Rheumatoid Arthritis Treatment: A Comprehensive Review.. Current Rheumatology Reviews, (2024). doi: 10.2174/0115733971294467240326074155.
  13. Turk MA, Liu Y, Pope JE. Non-pharmacological interventions in the treatment of rheumatoid arthritis: A systematic review and meta-analysis. Autoimmun Rev. 2023 Jun;22(6):103323. doi: 10.1016/j.autrev.2023.103323. Epub 2023 Mar 20. PMID: 36940841.
  14. Bora KS, Sharma A. The genus Artemisia: a comprehensive review. Pharm Biol. 2011 Jan;49(1):101-9. doi: 10.3109/13880209.2010.497815. Epub 2010 Aug 3. PMID: 20681755.
  15. Tan RX, Zheng WF, Tang HQ. Biologically active substances from the genus Artemisia. Planta Med. 1998 May;64(4):295-302. doi: 10.1055/s-2006-957438. PMID: 9619108.
  16. Dogra S, Singh J, Koul B, Yadav D. Artemisia vestita: A Folk Medicine with Hidden Herbal Fortune. Molecules. 2023 Mar 20;28(6):2788. doi: 10.3390/molecules28062788. PMID: 36985759; PMCID: PMC10054384.
  17. Yin Y, Gong FY, Wu XX, Sun Y, Li YH, Chen T, Xu Q. Anti-inflammatory and immunosuppressive effect of flavones isolated from Artemisia vestita. J Ethnopharmacol. 2008 Oct 30;120(1):1-6. doi: 10.1016/j.jep.2008.07.029. Epub 2008 Jul 31. PMID: 18721870.
  18. Manos C. Vlasiou ; Molecular Docking in Computer-Aided Drug Discovery: A Powerful Tool for Targeted Therapeutics, Computer-Aided Drug Discovery Methods: A Brief Introduction (2024) 1: 63.
  19. Samaresh Pal Roy ; Introduction to Computer-Based Simulations and Methodologies in Pharmaceutical Research, Software and Programming Tools in Pharmaceutical Research (2024) 1: 1. https://doi.org/10.2174/9789815223019124010003.
  20. Shamim S, Munawar R, Rashid Y, Muhammad Zesshan Qadar S, Bushra R, Begum I, et al. Molecular Docking: An Insight from Drug Discovery to Drug Repurposing Approach [Internet]. Unravelling Molecular Docking – From Theory to Practice [Working Title]. IntechOpen; 2024. Available from: http://dx.doi.org/10.5772/intechopen.1005526.
  21. Gangadharan, A.K., Kundil, V.T., Jayanandan, A. (2024). Computational Tools in Drug-Lead Identification and Development. In: Haridas, M., Abdulhameed, S., Francis, D., Kumar, S.S. (eds) Drugs from Nature: Targets, Assay Systems and Leads. Springer, Singapore. https://doi.org/10.1007/978-981-99-9183-9_4.
  22. Umi, Baroroh,, S.Si.,, M.Biotek.., Zahra, Silmi, Muscifa., Wanda, Destiarani., Fauzian, Giansyah, Rohmatullah., Muhammad, Yusuf. Molecular interaction analysis and visualization of protein-ligand docking using Biovia Discovery Studio Visualizer. (2023). doi: 10.24198/ijcb.v2i1.46322.
  23. Mohanraj, K., Karthikeyan, B. S., Vivek-Ananth, R. P., Chand, R. B., Aparna, S. R., Mangalapandi, P., & Samal, A. (2018). IMPPAT: A curated database of I ndian M edicinal P lants, P hytochemistry A nd T herapeutics. Scientific reports, 8(1), 4329.
  24. Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., Zaslavsky, L., Zhang, J., & Bolton, E. E. (2023). PubChem 2023 update. Nucleic Acids Res., 51(D1), D1373–D1380. https://doi.org/10.1093/nar/gkac956.
  25. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, P.E. Bourne, The Protein Data Bank (2000) Nucleic Acids Research 28: 235-242.
  26. Jejurikar, Bhagyashree L., and Sachin H. Rohane. “Drug designing in discovery studio.” (2021): 135-138.
  27. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. (2017) 7:42717.
  28. Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Research. 2021 Jul 2;49(W1):W5–14.
  29. Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol. 2015;1263:243-50. doi: 10.1007/978-1-4939-2269-7_19. PMID: 25618350.
  30. O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An open chemical toolbox. Journal of Cheminformatics. 2011 Oct 7;3(1):33.
  31. Michael, Boarder., Jane, Dixon., David, Newby., Phyllis, Navti., Tyra, Zetterström. Rheumatoid arthritis. (2016). doi: 10.1093/9780198728832.003.0009.
  32. Adhikari, MD G, Dhakal, MD B, Shrestha, MD S. Rheumatoid Arthritis – Symptoms and Treatment Demystified. AJPHI. 2024 Jun. 28;1(01). Available from: https://ajphi.org/ajphi/article/view/41.
  33. S.L., Hider., Sara, Muller., James, A., Prior., Toby, Helliwell., D., van, Schaardenburg., A., H., M., van, der, Helm-van, Mil., Karim, Raza., Christian, D, Mallen. (2017). SAT0708 Symptoms indicative of inflammatory arthritis are common in the primary care population: findings from the symptoms in persons at risk of rheumatoid arthritis survey. Annals of the Rheumatic Diseases, 76:1043-1043. doi: 10.1136/ANNRHEUMDIS-2017-EULAR.5503.
  34. Chenyu, Zhang., Peixiang, Ma., An, Qin., Liao, Wang., Kerong, Dai., Yuanyuan, Liu., Jie, Zhao., Zu, Hong, Lu. Current Immunotherapy Strategies for Rheumatoid Arthritis: The Immunoengineering and Delivery Systems. Research, (2023).;6 doi: 10.34133/research.0220.
  35. Bhashpitha Naredla, Usharani Sagarla, Prasanthi. D. Updates on Novel Treatments for Rheumatoid Arthritis. Research Journal of Science and Technology. 2023; 15(4):225-2. doi: 10.52711/2349-2988.2023.00.
  36. Tizaoui K, Terrazzino S, Cargnin S, Lee KH, Gauckler P, Li H, Shin JI, Kronbichler A. The role of PTPN22 in the pathogenesis of autoimmune diseases: A comprehensive review. Semin Arthritis Rheum. 2021 Jun;51(3):513-522. doi: 10.1016/j.semarthrit.2021.03.004.
  37. Budlewski T, Sarnik J, Galita G, Dragan G, Brzezińska O, Popławska M, Popławski T, Makowska J. SNP in PTPN22, PADI4, and STAT4 but Not TRAF1 and CD40 Increase the Risk of Rheumatoid Arthritis in Polish Population. Int J Mol Sci. 2023 Apr 20;24(8):7586. doi: 10.3390/ijms24087586.
  38. Yang C, Hu DH, Feng Y. Essential oil of Artemisia vestita exhibits potent in vitro and in vivo antibacterial activity: Investigation of the effect of oil on biofilm formation, leakage of potassium ions and survival curve measurement. Mol Med Rep. 2015 Oct;12(4):5762-70. doi: 10.3892/mmr.2015.4210. Epub 2015 Aug 11.
  39. Sary HG, Khedr MA, Orabi KY. Novel Vulgarin Derivatives: Chemical Transformation, In Silico and In Vitro Studies. Molecules. 2023 Apr 13;28(8):3421. doi: 10.3390/molecules28083421
  40. ElGamal RA, Galala AA, Abdel-Kader MS, Badria FA, Soliman AF. Microbial transformation of the sesquiterpene lactone, vulgarin, by Aspergillus niger. Molecules. 2023 Apr 26;28(9):3729.
  41. Ando M, Tajima K, Takase K. Studies on the syntheses of sesquiterpene lactones. III. Improved synthesis of vulgarin. Bulletin of the Chemical Society of Japan. 1979 Sep;52(9):2737-8..
Regular Issue Subscription Original Research
Volume 03
Issue 01
Received 27/12/2024
Accepted 09/01/2025
Published 30/01/2025
269